LEADER 02093nam a2200301 i 4500 001 991000159129707536 008 031204s2003 riua b 001 0 eng d 020 $a0821826239 035 $ab12578095-39ule_inst 040 $aDip.to Matematica$beng 082 0 $a515$221 084 $aAMS 01A 084 $aLC QA300.H55 2003 245 02$aA history of analysis /$cHans Niels Jahnke, editor 260 $aProvidence, RI :$bAmerican Mathematical Society ;$a[London] :$bLondon Mathematical Society ,$cc2003 300 $aix, 422 p. :$bill. ;$c27 cm 440 0$aHistory of mathematics,$x0899-2428 ;$v24 504 $aIncludes bibliographical references and indexes 505 0 $tAntiquity /$rRudiger Thiele.$tPrecursors of differentiation and integration /$rJan van Maanen.$tNewton's method and Leibniz's calculus /$rNiccolo Guicciardini.$tAlgebraic analysis in the 18th century /$rHans Niels Jahnke.$gThe$torigins of analytic mechanics in the 18th century /$rMarco Panza.$gThe$tfoundation of analysis in the 19th century /$rJesper Lutzen.$tAnalysis and physics in the nineteenth century: the case of boundary-value problems /$rTom Archibald.$tComplex function theory, 1780-1900 /$rUmberto Bottazzini.$tTheory of measure and integration from Riemann to Lebesgue /$rThomas Hochkirchen.$gThe$tend of the science of quantity: foundations of analysis, 1860-1910 /$rMoritz Epple.$tDifferential equations: a historical overview to circa 1900 /$rTom Archibald.$gThe$tcalculus of variations: a historical survey /$rCraig Fraser.$gThe$torigins of functional analysis /$rReinhard Siegmund-Schultze 650 0$aMathematical analysis$xHistory 650 0$aAnalyse mathématique$xHistoire 700 1 $aJahnke, Hans Niels$eauthor$4http://id.loc.gov/vocabulary/relators/aut$0151387 907 $a.b12578095$b09-03-22$c04-12-03 912 $a991000159129707536 945 $aLE013 01A JAH11 (2003)$g1$i2013000143545$lle013$op$pE98.05$q-$rl$s- $t0$u0$v0$w0$x0$y.i13075883$z10-02-04 996 $aHistory of analysis$91446474 997 $aUNISALENTO 998 $ale013$b04-12-03$cm$da $e-$feng$griu$h2$i3 LEADER 04705nam 2201225z- 450 001 9910557142003321 005 20210501 035 $a(CKB)5400000000040638 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/68385 035 $a(oapen)doab68385 035 $a(EXLCZ)995400000000040638 100 $a20202105d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aDiagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 online resource (240 p.) 311 08$a3-03943-685-6 311 08$a3-03943-686-4 330 $aAfter our successful first Special Issue about bladder cancer, we proceeded with the second issue. Again, many international scientists submitted their newest research results in that extremely interesting field and followed our call for submissions. It is not only the collection and combination of old and new markers that could develop new possibilities, but also the focus on different classifications and sub-classifications that will unveil new ways in diagnostic and therapeutic approaches. It seems that the two established diagnostic tools will still play an important role, but new markers and diagnostics tools will present more detailed and more differentiated possibilities in the treatment of urinary bladder cancer. This second Special Issue is full of scientific results that could provide new ways to help patients with instruments for early diagnostics and with predictive and prognostic markers on their way to finding new and personalized strategies for therapy. The editors thank all of the submitting authors for their efforts and time spent on each manuscript. We hope that this Special Issue will prove useful to research work in bladder cancer in the future. We hope that many talented researchers will use multiple forms of art to improve their professional successes and to ameliorate diagnostics and therapy in bladder cancer. 606 $aMedicine$2bicssc 610 $aadjuvant chemotherapy 610 $aandrogen receptor 610 $aBCG therapy 610 $abiomarker 610 $abiomarkers 610 $aBIRC5 610 $abladder 610 $abladder cancer 610 $abladder cancer detection 610 $acadmium exposure 610 $acancer 610 $achemotherapy 610 $acombination therapy 610 $aDNA methylation 610 $adrug resistance 610 $aECRG4 610 $aERBB2 610 $aF-actin 610 $aFGFR3 610 $agrade 610 $aheparan sulfate proteoglycans (HSPGs) 610 $aheparanase 610 $ahistone demethylase 610 $aimmunotherapy 610 $ainvasion 610 $aITIH5 610 $aJAK inhibitor 610 $aJAK-STAT pathway 610 $aKDM7A 610 $aKRT20 610 $amacrophage 610 $ametabolomics 610 $aMetallothionein 610 $aMIBC 610 $amiRNA 610 $aMS 610 $amuscle-invasive bladder cancer 610 $an/a 610 $aNMR 610 $anon muscle invasive bladder cancer 610 $anon-invasive detection 610 $aoncolytic adenovirus 610 $ap53 610 $apersonalized medicine 610 $aprediction 610 $apredictive biomarker 610 $aprognosis 610 $aproliferation 610 $aPTEN 610 $aquantitative PCR 610 $aRT-qPCR 610 $asomatic mutations 610 $aSTAT3/5 inhibitor 610 $asurvival 610 $asurvivin 610 $asyndecan-1 610 $aTAGLN 610 $aTC-E 5002 610 $atelomerase 610 $aTERT promoter mutations 610 $aTERT promoter region 610 $atumor marker 610 $atumor markers 610 $atumorigenesis 610 $aurinary biomarkers 610 $aurothelial cancer 610 $aurothelial carcinoma 610 $aurothelium 610 $avirotherapy 610 $avoided urine cytology 610 $aXVir-N-31 610 $azinc transporter 615 7$aMedicine 700 $aEcke$b Thorsten$4edt$01313317 702 $aOtto$b Thomas$4edt 702 $aEcke$b Thorsten$4oth 702 $aOtto$b Thomas$4oth 906 $aBOOK 912 $a9910557142003321 996 $aDiagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer ? Illumination of a Vision 2.0$93031280 997 $aUNINA